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Abstract
TM Ž .Atlas cDNA cell interaction arrays CLONTECH were used to examine degenerate tissue from four patients with
Achilles tendon disorders, in order to identify changes in expression of genes important in cellcell and cellmatrix
Ž .interactions. The greatest difference between normal post-mortem and degenerate tissue samples was in the level of MMP-3
Ž .stromelysin mRNA, which was down-regulated in all the degenerate samples. Quantitative RT-PCR assay of RNA extracted
from paired ‘normal’ and degenerate Achilles tendon tissue samples taken from tendons during surgery mirrored the results of
the arrays. Levels of MMP-3 mRNA were lower, whereas levels of type-I and type-III collagen mRNAs were significantly
higher, in the degenerate compared to the ‘normal’ samples. Immunoblotting of proteins extracted from the same tendon
samples showed that three of four normal tissue samples taken from individuals without apparent tendon disorder had much
higher levels of MMP-3 protein than ‘normal’ or degenerate samples from patients with tendinosis. We suggest that MMP-3
may play an important role in the regulation of tendon extracellular matrix degradation and tissue remodelling.  2001
Elsevier Science B.V.International Society of Matrix Biology. All rights reserved.
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1. Introduction
The most common finding during surgery for
chronic Achilles tendon pain is intratendinous degen-
Ž .eration or tendinosis Astrom and Rausing, 1995 .
Degenerate areas differ macroscopically from the sur-
rounding tissue by their soft, grey or yellowish, non-
Ž .glistening appearance Dahmen, 1964 . In a study of
342 operations for chronic Achilles tendon pain, 72%
Corresponding author. Tel.: 44-1223-216050; fax: 44-1223-
217838.
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of the tendons were found to have areas of intratendi-
nous degeneration while the rest showed no macro-
Ž .scopic pathology Astrom, 1998 .
Tendinosis is also found in the absence of symp-
toms. One-third of people over 35 years of age, with
no history of tendon problems, have degenerative
Ž .tendon changes Kannus and Jozsa, 1991 . Also, many
patients with ruptured Achilles tendons have no
symptoms beforehand, but degenerate tissue sur-
Žrounds the torn tendon tissue Astrom and Rausing,
.1995 . The tendinosis is generally thought to cause
Žthe rupture not result from it Kannus and Jozsa,
.1991; Gibson, 1998 .
Histopathological examination of normal Achilles
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tendon tissue samples taken at autopsy showed dense
straight or slightly wavy parallel-packed collagen
fibres with rows of cells, vessels and nerves located
Ž .between the fibre bundles Movin et al., 1997a . In
contrast, degenerate samples taken from 40 patients
with painful Achilles tendons showed: increased
amounts of non-collagenous matrix; alterations in the
structure and arrangement of collagen fibres; and
focal variations in cellularity and vascularization.
There was no infiltration of inflammatory cells in
these late stage samples. Recognising these features
Ž .of tendinosis, Khan et al. 1999 concluded that effec-
tive treatment of athletes with tendinopathies must
target this non-inflammatory condition. However, the
aetiology of tendinosis is unknown and the changes in
degenerate tissues have not been studied extensively.
The architecture of a tissue depends on cellular
interactions, both homo- and heterotypic cellcell
Žinteractions and cellmatrix interactions Petruzzelli
.et al., 1999 . Tenocytes produce both the components
of the extracellular matrix and also the enzymes that
degrade them. They produce adhesion molecules that
mediate cellular interactions and influence cell sig-
nalling, transcription and response to growth factors.
Mis-expression of matrix or adhesion molecules is the
underlying cause of many developmental or degenera-
Žtive disorders Lukashev and Werb, 1998; Petruzzelli
.et al., 1999 .
Regulation of tissue phenotype involves changes in
levels of individual mRNAs and the translation and
survival of their cognate proteins. We have used cDNA
arrays to examine the expression of a large number of
genes involved in cell interactions in both degenerate
and normal human Achilles tendon tissue samples in
order to identify differences that could account for
the degenerate phenotype. We have compared levels
of mRNA and protein for matrix metalloproteinase
MMP-3 in normal and degenerate samples.
2. Results
2.1. RNA extraction and quantification
The four samples of degenerate tendon tissue ob-
tained from patients undergoing surgery for Achilles
tendon disorders, and the three samples of normal
control tissue taken from a human cadaver, were
Žquite large and so three small pieces each approx. 50
.mg wet weight from each sample were used for RNA
extraction. The paired samples of degenerate and
normal tissue taken from the same tendon were
smaller. The average size of the first set of six paired
samples used for RNA extraction was 14 mg wet
Ž .weight range 922 mg . The average yield of total
RNA from the normal tissue samples was 45 ngmg
Ž .range 3057 and the average yield from the degen-
Ž .erate tissue samples was 51 ngmg range 2576 .
Gel analysis of the RNA showed it to be largely
undegraded.
2.2. cDNA expression arrays
32
P-labelled cDNA probes with total counts per
minute of 1.76.9106 were obtained from 1 to 2 g
total RNA using the AtlasTM array reagents. The
strongest signals, including those for GAPDH, were
visible on the film after overnight exposure of the
arrays, and the remaining signals were visible after 1
week. No signal corresponding to genomic DNA was
seen on any of the arrays.
The Atlas human cell-interaction arrays include
265 genes from different areas of cell interaction
research. Fig. 1 shows examples of autoradiographs
produced from normal and degenerate tendon tissue
samples. In all, 17 genes were up-regulated and 23
down-regulated in all the degenerate tissue samples
Žgreater than two-fold increase or decrease in nor-
malised signal, or detection in only normal or degen-
.erate tissue . Nine genes were up-regulated and two
down-regulated only in R1 and R2, and one gene was
up-regulated and two down-regulated only in T1 and
T2. Normalisation of the signals for specific genes to
those for beta-actin gave similar results to those ob-
tained using GAPDH. Fig. 2 shows the genes for
ECM and cell-adhesion molecules differentially ex-
pressed in degenerate and normal human Achilles
tendon tissue samples and includes some genes that
were differentially expressed in only three of the four
degenerate tissue samples. The results for the colla-
gens, non-collagen matrix components and matrix
Ž .metalloproteinases MMPs and their inhibitors are
shown in more detail in Tables 1, 2 and 3.
Table 1
Cellmatrix interactions  collagens
Collagen types Tendon sample
Normal T1 T2 R1 R2
I 0.16 2.6 2.5 2.3 0.89
II -1
III pro--1 0.06 2.6 1.9 2.4 1.02
IV 
IV -3
IX -1
VI -1 0.31 1.5 1.26 1.09 0.76
VI -2
VI -3 0.11 1.5 1.0 1.08 0.60
VIII -1 0.13 0.19 0.12
XI -1
XI pro--2 0.16 0.10
XVI -1 0.19 0.23 0.23 0.09
XVIII  0.09
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2.3. QC-RT-PCR and quantitatie RT-PCR using the
GeneAmp 5700 sequence detection system
QC-RT-PCR assays for type-I and type-III collagen
mRNAs in six pairs of Achilles tendon samples mir-
rored the results of the arrays. All of the six tendons
showed increased type-III collagen mRNA in the de-
generate tissue samples and five of the six tendons
showed increased type-I collagen mRNA in the de-
generate tissue samples.
A comparison of GAPDH mRNA levels in the first
six pairs of tendon samples obtained by using dupli-
cate samples in QC-RT-PCR and real-time quantita-
tive RT-PCR showed good concordance between the
two sets of results. The coefficients of variation of the
real-time assays ranged from 2.8 to 48%. Clearly,
more identical replicates were needed to give enough
precision to distinguish two-fold differences in mRNA
levels between paired tendon samples. Real-time RT-
PCR of RNAs from five more pairs of samples, using
five identical replicates of a single RNA preparation
per sample, showed significantly increased type-III
collagen mRNA in each degenerate sample compared
to its paired ‘normal’ sample when the data were
analysed using the approximate test. Three of the
pairs also had significantly increased type-I collagen
mRNA in the degenerate samples. Since only one
pair of samples could be taken from each patient, the
results of the two methods of RT-PCR were pooled to
give eleven pairs and the ratios degenerate‘normal’
Table 2
Cellmatrix interactions  other matrix components
Matrix components Tendon sample
Normal T1 T2 R1 R2
Fibronectin 0.05 0.13 0.11
Laminin 4 0.54 0.41 0.56 0.49
LAMB2 0.11 0.1 0.03
Laminin
Laminin B1 0.09 0.08
Laminin B2 0.07 0.08 0.08 0.09
Laminin 37 kDa 0.13 0.16 0.31 0.28
Netrin-2
Nidogen 0.14 0.06
SPARC 0.35 2.5 2.26 1.77 0.86
Tenascin-C 0.14 0.84 0.68 0.7 0.55
Tenascin-R
Thrombospondin 1
Thrombospondin 2 0.05 0.12 0.21 0.06
Versican 0.33 1.32 0.73 0.85 0.44
Vitronectin
HSPG2 0.12 0.45 0.39 0.42 0.36
Aggrecan 1 0.08
Biglycan 0.15 0.75 0.65 0.54 0.48
Decorin 0.84 1.26 0.61 0.58 0.55
Table 3
Cellmatrix interactions  matrix metalloproteinases and inhibi-
tors
MMPsTIMPs Tendon sample
Normal T1 T2 R1 R2
MMP-1
MMP-2 0.13 0.67 0.53 0.49 0.09
MMP-3 1.96 0.24
MMP-7
MMP-8
MMP-9 0.03 0.04
MMP-10
MMP-11
MMP-13 0.03 0.04
MMP-14 0.26 0.65 0.86 0.82 0.46
MMP-15
MMP-16 0.07 0.05 0.04 0.04 0.01
MMP-17 0.01
MMP-19 0.07 0.08 0.06 0.03
MDC9
TIMP-1 0.63 0.53 0.19 0.54 0.70
TIMP-2 0.28 0.26 0.23 0.23 0.09
TIMP-3 0.57 0.40 0.21 0.16 0.15
TIMP-4
-2-macroglobulin 0.12 0.04 0.05 0.05
EMMPRIN 1.21 0.38 0.09 0.25 0.30
Ž .plotted Fig. 3 . Statistical analysis by the Wilcoxon
signed rank sum test showed that the degenerate
samples had significantly increased type-III and type-I
Žcollagen mRNA compared to ‘normal’ samples P
.0.05 .
MMP-3 mRNA levels from the same pairs of sam-
ples were decreased in the isolates from degenerate
tissue. The normalised levels of MMP-3 mRNA in the
four normal cadaver samples varied considerably but
were higher than those in the degenerate samples of
Ž .the pairs Fig. 4 .
Results for real-time RT-PCR assay of MMP-2 and
TIMP-3 mRNAs in RNA samples from the first six
tendon pairs tested in duplicate are shown in Fig. 5.
Unfortunately, there was insufficient RNA in any of
the paired samples to allow for more replicates.
MMP-1 mRNA levels in all samples were very low or
undetectable.
2.4. Protein extraction and immunoblotting for MMP-3
The proteins isolated from the organic phase of the
Žextraction reagent with the exception of the ‘normal’
.sample of tendon eight gave similar patterns when
separated by gel electrophoresis and stained with
Ž .Coomassie Blue Fig. 6a . Immunoblotting showed
three of the four samples from individuals with no
apparent tendon disorders had much higher levels of
MMP-3 protein than those from patients with tendi-
Ž .nosis Fig. 6b .
( )D. Ireland et al.Matrix Biology 20 2001 159169162
TM 32 Ž .Fig. 1. Atlas cell-interaction arrays probed with P labelled cDNA probes made with total RNA from human Achilles tendons; a
Ž . Ž . Ž .degenerate tendon tissue T1 ; b normal tendon tissue. Spots surrounded by circles are types-I, -III and -VI alpha 1 and alpha 3 collagens,
which are up-regulated in degenerate tendon tissue. Spots surrounded by a square are MMP-3, which is down-regulated in degenerate tendon
tissue.
Tables 13 show expression of collagens, non-col-
lagen matrix components, MMPs and inhibitors tested
using cell-interaction arrays. Numbers are the ratios
for gene-specific signal signal for GAPDH. Genes
Ž .that showed increased expression  two fold in
degenerate Achilles tendon tissue samples are shown
in bold type while those that had increased expression
Ž .in normal tissue  two fold are shaded.
3. Discussion
Surgery for chronically painful Achilles tendons is
done at a late stage when non-operative treatment
has failed. Tissue samples can be taken for im-
munohistochemical and biochemical analyses, that
show the cumulative effects of cellular processes up
to the time of biopsy. This analysis of gene expression
in degenerate tissue from patients with Achilles tendi-
nopathies and in the corresponding normal tissue
from an age- and sex-matched cadaver has provided
information about the regulation of tissue phenotype
at the time that the samples were taken.
Ž .Marchuk et al. 1998 observed no degradation of
rRNA or loss of integrity of mRNA isolated from
rabbit ligament, tendon and cartilage up to 96 h
post-mortem. Their findings indicate that normal hu-
man tendon tissue removed 2 days post-mortem was
appropriate for this study. A pool of RNA extracted
from a number of normal tendons would have been
preferable to RNA from a single individual but the
choice was dictated by the poor availability of cadaver
tissue. The array results must be interpreted with
caution since they do not take into account the vari-
ability of specific RNA levels in normal Achilles ten-
don. Moreover, the characteristics and variations of
the hybridisation reactions make array data semi-
quantitative. Nonetheless, considered with both the
quantitative RT-PCR results described here, and the
results of earlier studies of tendinopathy, the findings
do suggest a number of alterations in gene expression
in tendinosis.
The ATLASTM cell interaction arrays carry cDNAs
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Fig. 2. Differential expression of genes for ECM and cell-adhesion molecules in degenerate and normal human Achilles tendon tissue
samples suggested by ATLASTM cDNA arrays. Altered expression in all four is shown in bold type; in R1 and R2 only is shown in italic type;
and in T1 and T2 only is shown in normal type.
for a number of the matrix metalloproteinases  a
family of neutral enzymes that can degrade all the
protein constituents of the ECM. Differences in MMP
RNA expression between normal and degenerate
Achilles tendon tissue samples were seen, with the
biggest change being down-regulation of MMP-3 in
the degenerate samples. RNAs from five pairs of
tendon samples tested with five replicates by quantita-
tive RT-PCR showed decreased MMP-3 RNAs in
degenerate tissues. Thus, the differences seen on the
gene arrays were not due to the different sources of
normal and degenerate tissue and were localised
within a tendon. The smaller differences between
‘normal’ and degenerate tissue samples from tendons
Ž .that had lesions, and normal post-mortem and de-
generate tissue samples, may reflect the difference
between the two types of normal sample. Normalised
levels of MMP-3 RNA in four normal cadaveric ten-
don tissue samples varied considerably but were higher
than the levels in the degenerate samples. Im-
munoblotting of proteins extracted from the same
tendon samples showed that three of the four normal
tissue samples taken from individuals without appar-
ent tendon disorder had much higher levels of MMP-3
protein than ‘normal’ or degenerate samples from
patients with tendinosis.
MMP-3 is an MMP with a wide substrate range
that includes most ECM components. It is also a
potent activator of other MMPs. Thus, it has the
potential to play a major role in regulation of tendon
ECM degradation and tissue remodelling. Evidence
for the importance of metalloproteases in maintaining
human tendon health came from the tendinitic effects
of marimastat, a broad-spectrum MMP inhibitor with
weak anti-sheddase action, used as an anti-cancer
agent. It is not clear which metalloproteases are in-
volved since neither collagenase- nor gelatinase-
specific inhibitors nor broad-spectrum MMP inhibi-
tors with strong anti-sheddase action induced tendini-
Ž .tis in a rat model Drummond et al., 1999 . Sheddase
activity is one of the functions of the adamalysins, cell
surface metalloproteases with properties of both ad-
Ž .hesion molecules and proteases Killar et al., 1999 .
cDNAs for these enzymes are not included on the
AtlasTM cell-interaction arrays and their contribution
to the degeneration of tendon tissue needs to be
investigated using other tools.
The broad substrate range of MMP-3 includes pro-
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Fig. 3. RT-PCR assays for type-III and type-I collagen mRNAs in
paired tissue samples from 11 patients with Achilles tendinosis.
Both type-I and type-III collagen mRNAs were significantly in-
Žcreased in degenerate tendon tissue samples Wilcoxon signed rank
.sum test: P0.05 .
teoglycans. Enhanced production of proteoglycans in
degenerate tendon tissue was suggested by the
observed increases in signals for perlecan, biglycan
Fig. 4. Real-time RT-PCR assay for MMP-3 mRNA in human
Achilles tendon tissue samples. Seven11  paired samples from
patients with tendinosis. N1 to N4  midsubstance tissue samples
from normal cadaveric tendons. A single RNA preparation per
sample was tested using five identical replicates. Ratios for normal
samples were calculated using the average value of the five degen-
erate samples from the pairs.
Fig. 5. Real-time RT-PCR assays for MMP-2 and TIMP-3 mRNAs
in paired tissue samples from six patients with Achilles tendinosis.
A single RNA preparation per sample was tested in duplicate.
and versican on the arrays. Increased proteoglycan
synthesis with decreased MMP-3 activity would ex-
plain the greater Alcian blue glycosaminoglycan stain-
ing seen in degenerate Achilles tendon tissue sec-
tions. Increased heparan sulfate binding of growth
factors may be responsible for the increased cellular-
Žity and angiogenesis seen in these tissues Movin et
.al., 1997a .
MMP-1 RNA was not detected in the samples
tested by gene array and the low levels of MMP-1
RNA in tendon tissue samples were confirmed by
RT-PCR assay of paired samples. There was no evi-
dence of increased levels of MMP-1 RNA in the
degenerate tissues of the paired samples. Although
MMP-1 and MMP-3 share homologous gene se-
quences and similar promoter elements, they do show
differential expression in response to several stimuli,
probably by recruiting different sets of transcription
Ž .factors Buttice et al., 1996 .
Ž .Levels of MMP-2 72 kDa gelatinase and MMP-14
Ž .MT1-MMP RNAs were increased in three out of
the four degenerate tendon tissue samples tested on
the arrays. MMP-14 is important for the physiological
activation of the inactive precursor form of MMP-2
Ž .Strongin et al., 1995 . However, RNAs from paired
samples from six tendons tested in duplicate by RT-
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Ž . Ž .Fig. 6. Coomassie Blue-stained 10% polyacrylamide gel A and immunoblot B of MMP-3 using soluble protein extracted from human
Achilles tendon tissue samples. M  molecular weight markers. S  purified MMP-3, 26 ng per track. Seven11  paired tendon tissue
samples from patients with tendinosis; ‘n’  macroscopically normal, d  degenerate. N1N4  midsubstance tissue samples from normal
Ž .cadaveric tendons. Soluble protein 2 g isolated from tissue samples were loaded per track.
PCR showed no trend towards increased MMP-2 RNA
in degenerate tissues.
Control over MMP activity involves inhibition of
active enzymes and activation of zymogens as well as
changes in gene expression. The balance of MMP and
TIMP activities determines the extent of ECM
turnover. We found no increases in TIMP RNA levels
but did find decreases in TIMP-3 RNA in the degen-
erate tissue samples tested on arrays. RNAs from
paired samples from six tendons tested in duplicate by
RT-PCR showed a trend towards decreased TIMP-3
RNA in degenerate tissues, but there was insufficient
material to confirm this with more replicates.
Differences in RNA levels for a number of collagen
types were seen in the normal and degenerate tissue
samples tested on the cDNA arrays. The greatest
up-regulation in degenerate samples was in the genes
for type-I and type-III collagens. RNAs from six pairs
of tendon samples tested in duplicate by RT-PCR
showed trends towards increased type-I and type-III
collagen RNAs in degenerate tissues. Differences were
significant when five replicates were used with RNAs
from a further five pairs of samples. There was a
greater increase in type-III collagen RNA than in
type-I collagen RNA in the degenerate tendon tissue
samples tested. This finding is in keeping with earlier
measurements of collagen proteins in tendinosis which
showed high levels of type-III collagen protein in both
Ž .degenerate equine tendon tissue Birch et al., 1998
and spontaneously ruptured human Achilles tendon
Ž .tissue Coombs et al., 1980 . Coombs and colleagues
postulated that a high proportion of type-III collagen
gives a tissue with reduced tensile strength and in-
creased susceptibility to rupture.
We have previously suggested that tendon pathology
may be linked to the development of fibrocartilage
Ž .Chard et al., 1993 but the low levels of type-II and
type-IX collagen RNAs and of aggrecan RNA in the
degenerate tendon tissue samples tested by array indi-
cated an absence of chondrocyte-like cells. Rather,
the array results suggest decrease in E-cadherin and
increase in SPARC and tenascin C RNAs in degener-
ate samples, possibly resulting in loss of cellcell
Ž .contact Sage and Bornstein, 1991 . Unfortunately
there was insufficient RNA from paired samples to
measure RNAs for these molecules.
Previous studies have shown no evidence of in-
flammation in biopsies from degenerate tendon tissue
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Ž .Movin et al., 1997a . The array results are in accor-
dance with these findings since degenerate tendon
tissue samples showed no increase in RNA for several
markers of lymphocytes, monocytes and granulocytes
Ž .CD70, CD27, CD30 and CD33 . Expression of CD4
RNA, expressed by T cells and macrophages, was
down-regulated in degenerate compared to normal
tendon tissue. RNAs for IL-1 and TNF , important
cytokine mediators of inflammation, were not de-
tected on cDNA arrays.
Biopsy studies represent the end-stage of tendon
disorders. It has been suggested that microtrauma
caused by repetitive mechanical load leads to an early
inflammatory phase followed by either healing or
failure to heal with subsequent degenerative changes.
Failure to heal has been attributed to decreased cell
activity resulting from reduced vascularity and relative
Žhypoxia at the site of the lesion Alkeminders and
.Temple, 1998 . This study demonstrates abundant cell
activity in degenerate Achilles tendon tissue samples
with increased expression of genes for type-I and
type-III collagens, and probably of genes for proteo-
glycans and other non-collagen proteins. There is
evidence that accumulation of proteoglycans results
from increased proteoglycan synthesis coupled with
reduced MMP-3 activity. Future studies using ultra-
sonography-guided percutaneous core biopsies taken
Žat earlier stages of tendon disorders Movin et al.,
.1997b are needed to determine the stage at which
the expression of genes becomes disregulated leading
to tissue degeneration.
4. Experimental procedures
4.1. Tendon specimens
Four samples of degenerate mid-substance tendon
tissue were obtained from patients undergoing surgery
Žfor Achilles tendon disorders. Two samples T1 and
.T2 were from patients with chronic tendon pain
Ž . Ž .male, aged 51 and 53 years and two R1 and R2
from patients with spontaneously ruptured tendons
Ž .male, aged 50 and 52 years . The ruptures had hap-
pened 35 weeks prior to surgery. Normal control
tissue was taken 2 days post-mortem from the corre-
sponding regions of a human cadaver Achilles tendon
Ž .male, aged 56 years .
Paired tendon specimens were taken from 11
patients undergoing surgery for chronic tendon pain
Ž .male, average age 33 years, range 3035 . One speci-
men of each pair came from the degenerate core
region and the other from a nearby site that was
macroscopically normal. The intervals between collec-
tion and freezing of tissue samples varied consider-
ably; only the two samples in a given pair had identi-
cal treatment. Frozen samples were stored in liquid
nitrogen or at 80C until used for RNA and protein
extraction.
4.2. RNA extraction and quantification
RNA was extracted by a modification of the TriSpin
Ž .method published by Reno et al. 1997 . A rotor
stator homogeniser was used to disrupt tendon tissue
samples in 1 ml of home-made monophasic reagent
containing phenol, isoamyl alcohol, guanidinium
Žisothiocyanate and beta-mercaptoethanol Weber et
.al., 1998 . The tissue samples were no more than
110 vol. of the reagent. After addition of 200 l of
chloroform, and centrifugation, RNA was extracted
from the aqueous phase using a commercially avail-
Žable RNA purification kit SV Total RNA Isolation
.System  Promega , according to the manufacturer’s
instructions. RNA was eluted from the spin columns
with 100 l of RNase-free water and quantified fluo-
Ž .rometrically using a RiboGreen kit Molecular Probes
containing a fluorescent RNA dye. RNA needed for
the preparation of labelled probes for cDNA expres-
sion array experiments was concentrated by alcohol
precipitation after the addition of 110 vol. of 2-M
sodium acetate. A sample of concentrated RNA was
run on a denaturing gel to check that it was largely
undegraded.
4.3. cDNA expression arrays
cDNA probes were prepared from 1 to 2 g total
RNA and hybridised to AtlasTM cell interaction arrays
Ž .CLONTECH using the kit reagents according to the
manufacturer’s instructions. Three samples of normal
tissue from the mid-portion of a human cadaver
Achilles tendon and one sample of each of the patient
Achilles tendons were used to probe the arrays.
Labelled probes bound to the arrays were detected
using BioMax MS film and intensifying screen
Ž .Kodak . The signals were quantified using Kodak 1D
image analysis software. The signals for all the genes
were then normalised to the signals for GAPDH and
-actin on the same array. The values for the four
degenerate tissue samples were then compared to
average values for the normal tissue. A gene was
recorded as up-regulated or down-regulated if the
difference was equal to or greater than two-fold.
( )D. Ireland et al.Matrix Biology 20 2001 159169 167
4.4. RT-PCR primers and probes
4.4.1. Cloning and QC-RT-PCR
GAPDH
Forward 5TGAAGGTCGGAGTCAACGGATTTG3
Reverse 5GTTGGTGGTGCAGGAGGCATTGCT3
Collagen type-I
Forward 5CCCCCTCCCCAGCCACAAAGA3
Reverse 5TCTTGGTCGGTGGGTGACTCT3
Collagen type-III
Forward 5CCAAACTCTATCTGAA3
Reverse 5GGACTCATAGAATACA3
MMP-1
Forward 5GAAAGGTGGACCAACAAT3
Reverse 5ACTTCTCCCGAATCGTA3
MMP-2
Forward 5CTACGACCGCGACAAGAAGTATG3
Reverse 3TGCCAAGGTCAATGACAGGA3
MMP-3
Forward 5TCACAGACCTGACTCGGTT3
Reverse 5CACGCCTGAAGGAAGAGAGATG3
TIMP-3
Forward 5CTTCTGCAACTCCGACATCGTG3
Reverse 5TGCCGGATGCAGGCGTAGTGTTT3
4.4.2. Quantitatie PCR using GeneAmp 5700 SDS
GAPDH
Forward 5TTTTAACTCTGGTAAAGTGGATATT
GTTG3
Reverse 5TGACCCAGCCATGGAATTT3
Probe 5ATTGACCTCAACTACATGGTTTACAT
GTTCCAATATG3
Collagen type-I
Forward 5CGCACGGCCAAGAGGAA3
Reverse 5CATGGTACCTGAGGCCGTTCT3
Probe 5ATTGACCTCAACTACATGGTTTACAT
GTTCCAATATG3
Collagen type-III
Forward 5AATAAACTTCAACACTCTTTATGATAA
CAACA3
Reverse 5ACTGGTGAGCACAGTCATTGCT3
Probe 5TGTGTTATATTCTTTGAATCCTAGCCCA
TCTGCA3
MMP-1
Forward 5TTTGATGTACCCTAGCTACACCTTCA3
Reverse 5AAAGGTTAGCTTACTGTCACATGCTTT3
Probe 5CCAAGCCATATATGGACGTTCCCAAAA
TCC3
MMP-2
Forward 5TACGACCGCGACAAGAAGTATG3
Reverse 3TTGTTGCCCAGGAAAGTGAAG3
Probe 5CCCTGAGACCGCCATGTCCACTGTT3
MMP-3
Forward 5CCTTTGATGCTGTCAGCACTCT3
Reverse 5GCAATTCAGGTTCAAGCTTCCT3
Probe 5TTTGCGCCAAAAGTGCCTGTCTTTAAA
GAT3
TIMP-3
Forward 5GCTGACAGGTCGCGTCTATGA3
Reverse 5GTAGCAGGACTTGATCTTGCAGTT3
Probe 5AGCTGGTCCCACCTCTCCACGAAGTT3
All primer pairs were chosen to include introns in
the gene sequences. Primer ExpressTM software was
used to design the primers and probes for use in the
GeneAmp 5700 SDS. Probes were chosen to span
intronexon boundaries so that they were unable to
hybridise to genomic DNA at the annealing tempera-
tures of the PCRs.
4.5. Preparation of RNA standards and mimics for QC-
RT-PCR
A sample of total RNA from a specimen of degen-
erate Achilles tendon was reverse transcribed using
random primers to give a pool of cDNA. This cDNA
was used to prepare PCR products for cloning into
Ž .the T-tailed vector pCR II-TOPO Invitrogen which
has both SP6 and T7 RNA polymerase promotor sites.
BamHI restriction sites were added to the forward
primers so that the orientation of each insert could be
determined by restriction of the plasmids with BamHI.
PCR products for type-I and -III collagen, MMP-1
and GAPDH and the corresponding mimics were
cloned. Forward primers extended at the 3 end with
nucleotides complementary to sequences approxi-
mately 60 bases downstream were used to create
mimics with the same 5 and 3 sequences as the
wild-type RNA, but with an internal deletion. This
allowed gel separation of wild-type and mimic PCR
products. Plasmids that contained inserts suitable for
transcription with SP6 RNA polymerase were selected
and cut with Not1. RNA transcripts were purified
Ž .using Microspin S-300 columns Pharmacia after
treatment with DNase1 to remove plasmid DNA. RNA
was quantified using a RiboGreen kit.
4.6. QC-RT-PCR
Total RNA was used in a QC-RT-PCR method in
which external standard curves were generated by
co-amplification of increasing amounts of in-vitro
transcribed wild-type RNA with a constant amount of
Ž . TMcompetitor mimic RNA Gerna et al., 1994 . Access
Ž .RT-PCR system reagents Promega were used for
single tube RT-PCR, with the dNTP mix in the kit
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Ž .replaced by a PCR DIG labelling mix Roche . PCR
Žproducts were separated on 4% Hi-Sieve Helena
.Biosciences agarose gels, blotted onto positively
charged nylon membrane, and fixed for 15 min at
120C. Labelled products were then detected using a
sheep anti-DIG-alkaline phosphatase conjugate,
TM Ž . Ž .CDP-Star Roche , and ECL-film Amersham . In-
dividual bands from scanned films were quantified
using the Kodak 1D image analysis program. The
signal ratio wild-typemimic was calculated for the
standards and samples, and sample values were calcu-
lated from the standard curve. Values for specific
mRNAs were normalised to GAPDH and expressed
as normalised ratios.
4.7. RT-PCR using GeneAmp 5700 SDS
Ž .One-step RT-PCR reagents Perkin-Elmer were
used in the GeneAmp 5700 SDS. A standard curve
prepared by dilution of in-vitro transcribed RNA was
included on each assay plate and the relative amounts
of specific mRNA in the samples calculated from this
Ž .curve. The first set 16 of tendon samples were
tested in duplicate and average values used for calcu-
Ž .lations. The second set 711 of samples were tested
using five identical replicates for each RNA sample,
and the mean values and standard deviations were
used to calculate the normalised ratios using the
formula
cvcv 2cv 2 where cvS.D.mean value1 2
to calculate the standard deviations of the quotients.
The means for each sample in the pairs were then
compared using the approximate test for unequal
Žvariances based on the t distribution Armitage and
.Berry, 1994 .
Since only one pair of samples could be taken from
each patient, the results of the two methods of RT-
PCR were pooled to give a total of 11 pairs and the
ratios degenerate‘normal’ plotted. The results were
analysed by the Wilcoxon signed rank sum test
Ž .Armitage and Berry, 1994 .
4.8. Extraction of soluble protein and immunoblotting
for MMP-3
Protein was isolated from the organic phase of the
extraction reagent after removal of the aqueous phase
containing RNA. After alcohol precipitation, the pro-
tein was dissolved in 1% SDS by heating for 30 min at
50C. The protein was quantified using the BCA pro-
Ž .tein assay reagent Pierce according to the manufac-
turer’s instructions. PAGE was used to separate the
polypeptides and gels were stained with Coomassie
blue or blotted onto PVDF membrane. Purified hu-
Ž .man MMP-3 CC1035-Chemicon was loaded onto
the same gels. The membranes were stained using a
Žmouse monoclonal antibody against MMP-3 ZIF 7103
. TCS Biologicals , and reagents from the West-
ernBreezeTM chemiluminescent immunodetection sys-
Ž .tem Novex . The results were visualised on Hyper-
Ž .filmMP Amersham film.
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